References
- Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-44. https://doi.org/10.1200/JCO.2005.04.4859
- Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36. https://doi.org/10.3322/caac.20121
- Jeremic B. Thoracic radiation therapy in extensive disease small cell lung Cancer. Int J Radiat Oncol Biol Phys 2015;93:7-9. https://doi.org/10.1016/j.ijrobp.2015.03.020
- Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-72. https://doi.org/10.1056/NEJMoa071780
- Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet 2015;385:36-42. https://doi.org/10.1016/S0140-6736(14)61085-0
- Giuliani ME, Atallah S, Sun A, et al. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Clin Lung Cancer 2011;12:375-9. https://doi.org/10.1016/j.cllc.2011.03.028
- Yee D, Butts C, Reiman A, et al. Clinical trial of postchemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer. Radiother Oncol 2012;102:234-8. https://doi.org/10.1016/j.radonc.2011.08.042
- Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47. https://doi.org/10.1016/j.ejca.2008.10.026
- Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 2006;24:2038-43. https://doi.org/10.1200/JCO.2005.04.8595
- Socinski MA, Smit EF, Lorigan P, et al. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensivestage small-cell lung cancer. J Clin Oncol 2009;27:4787-92. https://doi.org/10.1200/jco.2009.23.1548
- Zatloukal P, Cardenal F, Szczesna A, et al. A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. Ann Oncol 2010;21:1810-6. https://doi.org/10.1093/annonc/mdq036
- Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999;17:2092-9. https://doi.org/10.1200/JCO.1999.17.7.2092
- Luan Z, Wang Z, Huang W, et al. Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study. Exp Ther Med 2015;10:671-8. https://doi.org/10.3892/etm.2015.2526
- Gore EM, Hu C, Sun AY, et al. Randomized phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extracranial irradiation for extensive-disease small cell lung cancer (ED SCLC): NRG Oncology RTOG 0937. J Thorac Oncol 2017;12:1561-70. https://doi.org/10.1016/j.jtho.2017.06.015
- Beith JM, Clarke SJ, Woods RL, Bell DR, Levi JA. Longterm follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung. Eur J Cancer 1996;32A:438-43.
- Nou E, Brodin O, Bergh J. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens. Cancer 1988;62:1079-90. https://doi.org/10.1002/1097-0142(19880915)62:6<1079::AID-CNCR2820620610>3.0.CO;2-S
- Livingston RB, Moore TN, Heilbrun L, et al. Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. Ann Intern Med 1978;88:194-9. https://doi.org/10.7326/0003-4819-88-2-194
- Slotman BJ, Faivre-Finn C, van Tinteren H, et al. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: a secondary analysis of the Phase III CREST trial. Lung Cancer 2017;108:150-3. https://doi.org/10.1016/j.lungcan.2017.03.007
Cited by
- Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline vol.39, pp.8, 2021, https://doi.org/10.1200/jco.20.03364
- Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations vol.16, pp.1, 2021, https://doi.org/10.1186/s13014-021-01773-x